Total Clarity Wealth Management, Inc. Gilead Sciences, Inc. Transaction History

Total Clarity Wealth Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	BUY	$57.72 - $65.01 $104,300 - $117,473	1,807 New	1,807 $112,000
Q1 2022 Apr 29, 2022	SELL	$57.92 - $72.58 $48,131 - $60,313	-831 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$64.88 - $73.64 $4,346 - $4,933	67 Added 8.77%	831 $60,000
Q3 2021 Oct 21, 2021	BUY	$67.69 - $73.03 $51,715 - $55,794	764 New	764 $53,000
Q2 2021 Jul 26, 2021	SELL	$63.47 - $69.35 $61,185 - $66,853	-964 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$60.0 - $68.46 $57,840 - $65,995	964 New	964 $62,000
Q1 2020 Apr 24, 2020	SELL	$62.63 - $80.22 $18,162 - $23,263	-290 Closed	0 $0
Q4 2019 Feb 27, 2020	BUY	$61.62 - $67.78 $17,869 - $19,656	290 New	290 $19,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.